Health Sciences Acquisitions Corporation Units
HSACU
HSACU was delisted on the 18th of December, 2019.
31 hedge funds and large institutions have $98.6M invested in Health Sciences Acquisitions Corporation Units in 2019 Q2 according to their latest regulatory filings, with 31 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$11.2M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$10.6M |
| 3 |
GL
Governors Lane
New York
|
+$8.62M |
| 4 |
6CM
683 Capital Management
New York
|
+$8.33M |
| 5 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$7.08M |
Top Sellers
HSACU Hedge Fund Activity: Q2 2019 in Review
31 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Health Sciences Acquisitions Corporation Units (HSACU) for Q2 2019, worth a combined $98.6M.
Buyers outnumbered sellers: 31 funds opened new HSACU positions and 0 closed out — a net gain of 31 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Cormorant Asset Management, opening a new position worth an estimated $11.2M.
- 31 institutional investors held Health Sciences Acquisitions Corporation Units (HSACU) as of Q2 2019, up from 0 in Q1 2019.
- Funds reported $98.6M of Health Sciences Acquisitions Corporation Units stock for Q2 2019.
- 31 funds opened new Health Sciences Acquisitions Corporation Units positions in Q2 2019 and 0 closed out, a net change of +31 holders.
- The largest Health Sciences Acquisitions Corporation Units buyer in Q2 2019 was Cormorant Asset Management, an estimated $11.2M added.
Based on aggregated 13F filings for Q2 2019.